People with ADHD face a higher risk of death than people without the condition, according to a systematic review and meta-analysis published in JAMA Network Open. The review pools data from 19 studies involving roughly 15.9–16 million participants and reports that people with ADHD have about a 71% higher hazard of death overall. It also finds higher risks for specific causes, including suicide-related death and fatalities from injury.
The same review reports that ADHD medication is associated with a lower risk of death, with one pooled analysis suggesting reduced hazard for those who needed treatment. The medication finding is presented as correlational: the authors stress that only a few studies contribute to that estimate and that confounding factors—such as access to healthcare and socioeconomic status—may influence results.
Across coverage, outlets largely agree on the headline numbers (about 71% higher all-cause hazard) and the overall framing that treatment may be beneficial. Differences mainly involve emphasis: some focus more on the medication angle, while others highlight the mortality association first, with context that the data do not prove cause and effect for medication’s effects.
